The Food and Drug Administration earlier this week threatened to pull e-cigarettes from shelves if manufacturers do not control teen use.
Gottlieb makes his comments a day after the FDA ordered Juul and four other vaping brands to submit plans to discourage teen use of their products within 60 days.
U.S. Health and Human Services Secretary Alex Azar said it was within his agency's power to eliminate rebates on prescription drug purchases.
CVS says it returns about 98 percent of rebates to its customers. It expects to keep about $300 million this year, representing about 3 percent of its annual adjusted earnings per share.
The Centers for Medicare & Medicaid Services will allow Medicare Advantage plans to negotiate prices of medicines covered under Medicare Part B, which covers drugs typically administered by a physician.
Shares of Health Insurance Innovations and eHealth rose after the Trump administration issued a final rule that eases restrictions on short-term health plans under the Affordable Care Act.
Insurers will be able to start selling short-term coverage that's cheaper and less comprehensive than Obamacare plans, starting in October.
Pfizer found itself at the center of the price debate earlier this month when President Donald Trump publicly condemned Pfizer for raising the price of some of its drugs.
Investors welcome Lilly's decision to file an initial public offering for its Elanco animal health unit.
The Food and Drug Administration is forming a working group to consider allowing short-term importation of foreign versions of medicines facing “access dislocations.”
The Trump administration claims it completed the first round of reunifications Thursday of families separated at the border, according to USA Today.
Alex Azar said federal health officials are working overtime to confirm that immigrant children will be placed with their actual parents per a pending court order.
Concierge medicine and other fee-based primary care practices make up less than 10 percent of physician practices.
Officials did not have data on how many children had been reunited with their parents, nor on how border patrol officers determine whether children are too young to separate from their mothers.
Firms negotiate discounts, or rebates, down from the list price drugmakers set. Critics argue the practice inflates drug prices because it encourages manufacturers to set higher prices.
Former Celgene CEO Bob Hugin is trying to take down scandal-wracked New Jersey Sen. Bob Menendez in what could become a nasty race.
While signing "right-to-try" legislation into law, Trump touted his administration's moves to lower prescription drug prices.
Biotech companies and pharmacy benefit managers are outperforming the market, despite new pressure on drugmakers.
President Donald Trump unveiled his blueprint to lower drug prices, called "American Patients First," in a highly anticipated speech on Friday. However, his actions weren't as biting as his words suggested.
"Just raising the prices across the world isn't going to help America," former Health and Human Services Secretary Tommy Thompson says.